Treatment of Subclinical Hypothyroidism
Treatment decisions for subclinical hypothyroidism should be based primarily on TSH level thresholds: routine levothyroxine treatment is NOT recommended for TSH 4.5-10 mIU/L, but IS reasonable for TSH >10 mIU/L, with pregnancy being an absolute indication for treatment regardless of TSH level. 1
Treatment Algorithm by TSH Level
TSH 4.5-10 mIU/L (Mild Subclinical Hypothyroidism)
Do NOT routinely treat with levothyroxine 1. The evidence is clear:
- No studies demonstrate decreased morbidity or mortality with treatment
- RCTs restricted to TSH <10 mIU/L found no improvement in symptoms with levothyroxine 1
- Treatment does not improve symptoms or cognitive function in this range 2
Management approach:
- Monitor thyroid function tests every 6-12 months 1
- Consider a several-month trial of levothyroxine ONLY if the patient has clear hypothyroid symptoms 1
- Continue therapy ONLY if there is clear symptomatic benefit 1
- Understand that likelihood of improvement is small and must be balanced against risks (14-21% develop subclinical hyperthyroidism with treatment) 1
TSH >10 mIU/L (Severe Subclinical Hypothyroidism)
Levothyroxine therapy is reasonable and should be initiated 1. Rationale:
- 5% annual progression rate to overt hypothyroidism
- Treatment may prevent manifestations and consequences of hypothyroidism
- More compelling basis for treatment at this threshold 1
Initial dosing: 25-75 µg daily depending on degree of TSH elevation, adjusted based on clinical response and follow-up TSH 3
Special Populations Requiring Treatment
Pregnancy and Women Planning Pregnancy
ALWAYS treat with levothyroxine to restore TSH to reference range 1. This is based on:
- Possible association with increased fetal wastage
- Risk of neuropsychological complications in offspring 1
- Potential benefit-risk ratio justifies treatment despite lack of intervention trials 1
Target TSH levels during pregnancy:
Monitoring: Check TSH every 4 weeks during first half of pregnancy and at least once between 26-32 weeks 3
Age Considerations
Elderly patients (≥65-70 years): Exercise caution with treatment 2, 4, 5
- Treatment may be harmful in elderly patients with subclinical hypothyroidism 2
- No evidence of benefit in persons aged 65 years or older 4
- LT4 treatment generally NOT recommended for elderly patients regardless of SCH severity 5
- TSH upper limit of normal is age-dependent: 7.5 mIU/L for patients >80 years 2
Younger patients (<65 years): May benefit from treatment, especially with cardiovascular risk factors 6, 4, 5
Medication Specifics
Levothyroxine is the ONLY recommended treatment:
- Take with water 30-60 minutes before breakfast or at bedtime 4 hours after last meal 3
- Desiccated thyroid hormone should NOT be used 3
- Levothyroxine/liothyronine combinations should NOT be used in pregnant women or those planning pregnancy 3
Critical Pitfalls to Avoid
Confirm the diagnosis: Repeat TSH measurement at minimum 2 weeks but no longer than 3 months after initial assessment 1. 62% of elevated TSH levels may revert to normal spontaneously 2
Don't overtreat: 14-21% of patients treated with levothyroxine develop iatrogenic subclinical hyperthyroidism 1
Don't expect symptom improvement in mild disease: Symptoms related to vitality, weight, and quality of life often persist with levothyroxine treatment when TSH <10 mIU/L 6
Age matters: What benefits younger patients may harm elderly patients 2, 4, 5
Pregnancy changes everything: Even mild TSH elevations require treatment in pregnancy or when planning pregnancy 1